Showing results (2251-2260 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|February 24, 2001
Quinupristin/dalfopristin: a therapeutic reviewD R Allington, M P RiveyClinical Therapeutics|February 24, 2001
Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trialA G Olsson, P Pauciullo, V Soska, et al.Clinical Therapeutics|October 9, 2001
Rofecoxib: clinical pharmacology and clinical experienceA L WeaverClinical Therapeutics|October 9, 2001
A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoateC Crim, L N Pierre, P T Daley-YatesClinical Therapeutics|October 9, 2001
Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of strokeA R Redman, G J RyanClinical Therapeutics|October 9, 2001
Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placeboS I Harris, M Kuss, R C Hubbard, et al.Clinical Therapeutics|October 9, 2001
Factors associated with clinical assessment of overactive bladder and selection of treatmentA Diokno, P Lee, B H Zorn, et al.Clinical Therapeutics|October 9, 2001
Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemiaL Mosca, K Harper, S Sarkar, et al.Clinical Therapeutics|October 9, 2001
Methodology for identifying patients at high risk for osteoporotic fractureG Westfall, R Littlefield, A Heaton, et al.Clinical Therapeutics|July 7, 2001
Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's diseaseJ NajibPageof 680